نتائج البحث - "Receptors, KIR3DL2"

1

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

المؤلفون: Maarten H. Vermeer, Martine Bagot, Federico Rotolo, Cécile Bonnafous, Hélène Sicard, Anne Marie-Cardine, Hatem A. Azim, Caroline Ram-Wolff, Sean Whittaker, Maxime Battistella, Michael S. Khodadoust, Carine Paturel, Armand Bensussan, Pierluigi Porcu, Basem M. William, Youn H. Kim

المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie, dermatologie, oncologie, Oncodermatologie, immunologie et cellules souches cutanées (IDO (U976 / UMR_S 976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Gvh et Gvl : Physiopathologie Chez l'Homme et Chez l'Animal, Incidence et Role Therapeutique, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Dermatologie [AP-HP Hôpital Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Recherche & Développement, Innate Pharma

المصدر: Lancet Oncology
Lancet Oncology, Elsevier, 2019, 20 (8), pp.1160-1170. ⟨10.1016/S1470-2045(19)30320-1⟩

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, Maximum Tolerated Dose, [SDV]Life Sciences [q-bio], Population, Phases of clinical research, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, education, ComputingMilieux_MISCELLANEOUS, Aged, education.field_of_study, Mycosis fungoides, Dose-Response Relationship, Drug, business.industry, Cutaneous T-cell lymphoma, Not Otherwise Specified, Receptors, KIR3DL2, Middle Aged, medicine.disease, Lymphoma, T-Cell, Cutaneous, 3. Good health, Lymphoma, Clinical trial, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ce3c922b3a855c25f033db0b020d6bTest
https://doi.org/10.1016/s1470-2045Test(19)30320-1

2

Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma

المؤلفون: Anish Chakka, Fernando Concha-Benavente, Robert L. Ferris, Uma R. Chandran, Daniel L. Faden, Elizabeth L. McMichael

المصدر: Head Neck

مصطلحات موضوعية: Adult, Male, medicine.drug_class, Cetuximab, HLA-C Antigens, Human leukocyte antigen, Monoclonal antibody, Article, Cohort Studies, Interferon-gamma, 03 medical and health sciences, Alkaloids, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, Receptors, KIR, Epidermal growth factor, Cell Line, Tumor, Exome Sequencing, otorhinolaryngologic diseases, medicine, Humans, Interferon gamma, neoplasms, Aged, HLA-A Antigens, business.industry, Histocompatibility Antigens Class I, Head and neck cancer, Receptors, KIR3DL2, Middle Aged, medicine.disease, Head and neck squamous-cell carcinoma, Up-Regulation, Killer Cells, Natural, stomatognathic diseases, Otorhinolaryngology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Mutation, Carcinoma, Squamous Cell, Cancer research, Female, business, Signal Transduction, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb9efb8c16adbacf934f5a22e448a73Test
https://doi.org/10.1002/hed.25726Test

3

KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia

المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Cancer et Transplantation : Physiopathologie et Réponse Thérapeutique (UMR 1165), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Innate Pharma, AP-HP - Hôpital Bichat - Claude Bernard [Paris], leboeuf, Christophe

المصدر: British Journal of Dermatology
British Journal of Dermatology, 2018, 179 (1), pp.197-199. ⟨10.1111/bjd.16322⟩

مصطلحات موضوعية: Adult, Male, Leukemia lymphoma, Skin Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Dermatology, MESH: Receptors, KIR3DL2, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, MESH: Skin, [SDV.CAN] Life Sciences [q-bio]/Cancer, Medicine, Humans, Leukemia-Lymphoma, Adult T-Cell, In patient, MESH: Leukemia-Lymphoma, Adult T-Cell, Receptor, Skin pathology, Survival analysis, Aged, Skin, MESH: Aged, MESH: Humans, MESH: Middle Aged, business.industry, MESH: Skin Neoplasms, Adult T-cell lymphoma/leukaemia, Receptors, KIR3DL2, MESH: Adult, Middle Aged, Survival Analysis, MESH: Male, KIR3DL2, 030220 oncology & carcinogenesis, MESH: Survival Analysis, Cancer research, Female, business, MESH: Female